abagovomab 28
abciximab 24
abituzumab 24
abrilumab 13
actoxumab 11
adalimumab 15
aducanumab 10
afasevikumab 12
alacizumab_pegol 8
alemtuzumab 23
alirocumab 16
amatuximab 35
andecaliximab 21
anifrolumab 18
anrukinzumab 17
aprutumab 16
aprutumab_ixadotin 16
arcitumomab 17
ascrinvacumab 4
atezolizumab 14
atinumab 14
avelumab 9
basiliximab 25
bavituximab 29
begelomab 23
benralizumab 25
bevacizumab_beta 21
bezlotoxumab 11
bimagrumab 15
bleselumab 9
blinatumomab 23
blosozumab 29
bococizumab 17
brazikumab 18
brentuximab_vedotin 22
briakinumab 19
brodalumab 10
brolucizumab 28
brontictuzumab 25
burosumab 18
cabiralizumab 26
camrelizumab 13
canakinumab 22
cantuzumab_ravtansin 37
carlumab 13
carotuximab 13
cergutuzumab_amunaleukin2 26
cergutuzumab_amunaleukin 26
certolizumab_pegol 27
cetiximab 32
citatuzumab_bogatox 28
cixutumumab 22
clivatuzumab_tetraxetan 18
codrituzumab 22
conatumumab 13
concizumab 18
crenezumab 19
crizanlizumab 23
crotedumab 19
dacetuzumab 22
daclizumab 16
dalotuzumab 27
dapirolizumab_pegol 23
daratumumab 12
dectrekumab 10
demcizumab 22
denosumab 8
depatuxizumab 19
depatuxizumab_mafodotin 19
dezamizumab 22
dinutuximab 30
diridavumab 21
domagrozumab 16
drozitumab 13
duligotuzumab 20
durvalumab 8
dusigitumab 19
efalizumab 35
efungumab 22
eldelumab 14
elezanumab 17
elgemtumab 10
elotuzumab 15
emactuzumab 16
emapalumab 22
emibetuzumab 19
enavatuzumab 23
enfortumab_vedotin 14
enoblituzumab 17
enokizumab 25
enoticumab 18
ensituximab 23
eptinezumab 13
erenumab 18
etaracizumab 14
etrolizumab 23
evinacumab 20
evolocumab 16
farletuzumab 3
fasinumab 17
fezakinumab 22
fibatuzumab 9
ficlatuzumab 25
firivumab 25
flanvotumab 16
fletikumab 21
foralumab 13
foravirumab 15
fremanezumab 29
fresolimumab 16
fulranumab 20
futuximab 18
galcanezumab 15
ganitumab 20
gantenerumab 13
gemetuzumab 29
gemtuzumab2 19
gemtuzumab 23
gevokizumab 21
girentuximab 23
glembatumumab 18
glembatumumab_vedotin 18
guselkumab 19
ibalizumab 29
ibritumomab 22
icrucumab 11
idarucizumab 24
ifabotuzumab 9
imalumab 15
imgatuzumab 21
inclacumab 20
indatuximab_ravtansin 24
indusatumab 18
inebilizumab 22
intetumumab 6
iodine_girentuximab 29
ipilimumab 3
iratumumab 8
isatuximab 28
itolizumab 22
ixekizumab 26
labetuzumab_govitecan 23
lambrolizumab 28
lampalizumab 25
lanadelumab 19
landogrozumab 15
laprituximab 27
lebrikizumab 30
lendalizumab 25
lenzilumab 16
lifastuzumab_vedotin 24
ligelizumab 23
lilotomab 29
lirilumab 21
lodelcizumab 16
lokivetmab 16
lorvotuzumab_mertansin 17
lucatumumab 30
lumretuzumab 19
lupartumab 17
lutikizumab 16
margetuximab 30
milatuzumab 28
mirvetuximab 29
mirvetuximab_soravtansin 29
modotuximab 39
mogamulizumab 22
monalizumab 19
motavizumab 28
moxetumomab_pasudotox 19
namilumab 20
naratuximab 26
naratuximab_emtansin 26
narnatumab 15
navicixizumab2 28
navicixizumab 24
navivumab 30
necitumumab 10
nemolizumab 27
nesvacumab 14
nivolumab 12
obiltoxaximab 21
obinutuzumab 30
ocaratuzumab 21
ofatumumab 14
olaratumab 14
olokizumab 24
omalizumab 18
onartuzumab 22
ontuxizumab 25
opicinumab 13
orticumab 11
otelixizumab 36
oxelumab 10
ozanezumab 25
pamrevlumab 11
panobacumab 19
parsatuzumab 27
pasotuxizumab 17
pateclizumab 15
patritumab 15
pembrolizumab 28
perakizumab 22
pidilizumab 14
pinatuzumab_vedotin 16
plozalizumab 23
pogalizumab 24
polatuzumab_vedotin 20
ponezumab 27
prezalumab 14
pritoxaximab 32
quilizumab 19
racotumomab 28
radretumab 13
ralpancizumab 22
ramucirumab 11
ranevetmab 28
ranibizumab 20
refanezumab 22
remtolumab 19
rilotumumab 14
rinucumab 16
risankizumab 31
rituximab 19
rivabazumab 22
robatumumab 20
roledumab 29
romosozumab 22
rontalizumab 21
rosmantuzumab 23
rozanolixizumab 19
sacituzumab 27
sacituzumab_govitecan 27
samalizumab 25
sapelizumab 22
sarilumab 17
secukinumab 14
seribantumab 15
setoxaximab 33
sifalimumab 10
siltuximab 17
simtuzumab 26
sirukumab 9
solanezumab 26
solitomab 23
stamulumab 15
suptavumab 22
suvizumab 15
tabalumab 15
tadocizumab 18
tamtuvetmab 29
tanezumab 21
tarextumab 11
tavolixizumab 12
telisotuzumab 30
teplizumab 17
tesidolumab 19
tezepelumab 22
tigatuzumab 15
tildrakizumab 21
timolumab 13
tisotumab 11
tosatoxumab 28
tositumomab 19
tralokinumab 25
trastuzumab 24
tregalizumab 21
trevogrumab 12
ublituximab 16
urelumab 14
ustekinumab 26
utomilumab 21
vadastuximab 25
vadastuximab_talirin 25
vandortuzumab_vedotin 18
vantictumab 16
vanucizumab2 21
vanucizumab 26
varlilumab 16
vatelizumab 19
vedolizumab 24
veltuzumab 10
vesencumab 9
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 30
xentuzumab 17
zatuximab 39
